Elicio Therapeutics (ELTX) Interest & Investment Income (2023 - 2026)
Elicio Therapeutics' (ELTX) quarterly Interest & Investment Income came in at $157000.0 in Q1 2026, down 25.24% YoY from $210000.0 in Q1 2025, and down 21.11% on a QoQ basis from $199000.0 in Q3 2025.
Elicio Therapeutics (ELTX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has 4 years of Interest & Investment Income data on file, last reported at $157000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - | 138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138,000.00 |
| Mar 31, 2026 | 157,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 168,000.00 |
| Mar 31, 2025 | 210,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 137,000.00 |
| Sep 30, 2023 | 246,000.00 |
| Jun 30, 2023 | 39,000.00 |